Search

everythinglearnresearchcommunity

for

Search:↓

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Tofacitinib is an effective and safe treatment for alopecia areata.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

The FDA approved a new Pfizer drug for hair loss in teens.

An arthritis drug helped a person with severe hair loss regrow their hair.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Dupilumab helped a 13-year-old regrow hair after alopecia totalis.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.